Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, will take part in a “Keynote Panel Discussion: Mobile Medical Regulation in the U.S. and Worldwide” at the 4th Annual mHealth World Congress.
- Will FDA guidelines for regulating mobile apps inhibit the mobile growth market?
- How do the U.S. guidelines compare with those in other countries and what has been the impact on innovation?
- Hear an update from the FDA on the draft guidelines for mobile apps in 2012
- Discuss ways to harmonize and simplify medical device regulation (e.g. connected medical devices) around the world without sacrifices to safety
For more information, visit World Congress.